Sage Therapeutics, Inc. Payments for Restructuring
Sage Therapeutics, Inc. reported Payments for Restructuring of $13.42 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2025-07-30
- Sage Therapeutics, Inc. payments for restructuring for the quarter ending 2025-06-30 was $4.37M, a 142.19% increase year-over-year.
- Sage Therapeutics, Inc. payments for restructuring for the quarter ending 2025-03-31 was $9.04M, a 21.79% increase year-over-year.
- Sage Therapeutics, Inc. payments for restructuring for the quarter ending 2024-12-31 was $7.10M.
- Sage Therapeutics, Inc. payments for restructuring for the quarter ending 2024-09-30 was $610.00K, a 89.33% decline year-over-year.
- Sage Therapeutics, Inc. payments for restructuring for fiscal 2024 was $16.94M, a 11.61% decline from fiscal 2023.
- Sage Therapeutics, Inc. payments for restructuring for fiscal 2023 was $19.16M.
- Sage Therapeutics, Inc. payments for restructuring for fiscal 2021 was $203.00K, a 99.19% decline from fiscal 2020.
- Sage Therapeutics, Inc. payments for restructuring for fiscal 2020 was $25.10M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2025-06-30 | $4.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $13.42M 10-Q · filed 2025-07-30 | $20.52M derived: sum of 3 quarters · filed 2025-07-30 | $21.13M derived: sum of 4 quarters · filed 2025-07-30 |
| 2025-03-31 | $9.04M 10-Q · filed 2025-04-29 | $16.14M derived: sum of 2 quarters · filed 2025-04-29 | $16.75M derived: sum of 3 quarters · filed 2025-04-29 | $18.56M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $7.71M derived: sum of 2 quarters · filed 2025-02-11 | $9.52M derived: sum of 3 quarters · filed 2025-07-30 | $16.94M 10-K · filed 2025-02-11 |
| 2024-09-30 | $610.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $2.42M derived: sum of 2 quarters · filed 2025-07-30 | $9.84M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $9.23M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $7.42M 10-Q · filed 2025-04-29 | |||
| 2023-12-31 | $19.16M 10-K · filed 2025-02-11 | |||
| 2023-09-30 | $5.71M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $203.00K 10-K · filed 2022-02-24 | |||
| 2020-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $25.10M 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $24.08M 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | $14.56M 10-Q · filed 2020-08-10 |